Recent developments in ovarian cancer screening
暂无分享,去创建一个
U Menon | I. Jacobs | U. Menon | I J Jacobs
[1] N. Urban. Screening for ovarian cancer , 1999, BMJ.
[2] P. Pharoah,et al. Screening for breast and ovarian cancer: the relevance of family history. , 1998, British medical bulletin.
[3] M. Law,et al. The importance of age in screening for cancer , 1999, Journal of medical screening.
[4] R. Kryscio,et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. , 1998, Gynecologic oncology.
[5] Steven J Skates,et al. Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.
[6] I. Jacobs,et al. The Role of CA 125 in Screening for Ovarian Cancer , 1998, The International journal of biological markers.
[7] J. Chang-Claude,et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. , 1998, European journal of cancer.
[8] D. Aoki,et al. Clinical characteristics of a newly developed ovarian tumour marker, galactosyltransferase associated with tumour (GAT). , 1998, European journal of cancer.
[9] D. Oram,et al. A comparison of national cancer registry and direct follow-up in the ascertainment of ovarian cancer , 1999, British Journal of Cancer.
[10] R. Bast,et al. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers , 1995, Cancer.
[11] R. L. Baldwin,et al. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening. , 1999, American journal of obstetrics and gynecology.
[12] J. Canick,et al. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. , 1997, Gynecologic oncology.
[13] Usha Menon,et al. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening , 2000, BJOG : an international journal of obstetrics and gynaecology.
[14] I. Jacobs,et al. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation , 1999, British Journal of Cancer.
[15] P. Kenemans,et al. CA 125: fundamental and clinical aspects. , 1999, Seminars in cancer biology.
[16] M Markman,et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.
[17] D. Parkin,et al. The performance of screening tests for ovarian cancer: results of a systematic review , 1999, British journal of obstetrics and gynaecology.
[18] T. Miyamoto,et al. Bilateral Oophorectomy in Asymptomatic Women over 50 Years Old Selected by Ovarian Cancer Screening , 1999, Gynecologic and Obstetric Investigation.
[19] C. Sohn,et al. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study. , 1998, Gynecologic oncology.